Literature DB >> 28188325

Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients.

Charles Lemarignier1,2, Antoine Martineau3, Luis Teixeira4,5, Laetitia Vercellino3, Marc Espié4,5, Pascal Merlet3, David Groheux3,5.   

Abstract

PURPOSE: The study was designed to evaluate 1) the relationship between PET image textural features (TFs) and SUVs, metabolic tumour volume (MTV), total lesion glycolysis (TLG) and tumour characteristics in a large prospective and homogenous cohort of oestrogen receptor-positive (ER+) breast cancer (BC) patients, and 2) the capability of those parameters to predict response to neoadjuvant chemotherapy (NAC).
METHODS: 171 consecutive patients with large or locally advanced ER+ BC without distant metastases underwent an 18F-FDG PET examination before NAC. The primary tumour was delineated with an adaptive threshold segmentation method. Parameters of volume, intensity and texture (entropy, homogeneity, contrast and energy) were measured and compared with tumour characteristics determined on pre-treatment breast biopsy (Wilcoxon rank-sum test). The correlation between PET-derived parameters was determined using Spearman's coefficient. The relationship between PET features and pathological findings was determined using the Wilcoxon rank-sum test.
RESULTS: Spearman's coefficients between SUVmax and TFs were 0.43, 0.24, -0.43 and -0.15 respectively for entropy, homogeneity, energy and contrast; they were higher between MTV and TFs: 0.99, 0.86, -0.99 and -0.87. All TFs showed a significant association with the histological type (IDC vs. ILC; 0.02 < P < 0.03) but didn't with immunohistochemical characteristics. SUVmax and TLG predicted the pathological response (P = 0.0021 and P = 0.02 respectively); TFs didn't (P: 0.27, 0.19, 0.94, 0.19 respectively for entropy, homogeneity, energy and contrast).
CONCLUSIONS: The correlation of TFs was poor with SUV parameters and high with MTV. TFs showed a significant association with the histological type. Finally, while SUVmax and TLG were able to predict response to NAC, TFs failed.

Entities:  

Keywords:  18F-FDG PET; Breast cancer; Metabolic tumour volume; Oestrogen receptor-positive tumour; Texture features; Total lesion glycolysis

Mesh:

Substances:

Year:  2017        PMID: 28188325     DOI: 10.1007/s00259-017-3641-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  34 in total

1.  Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models.

Authors:  S Vauclin; K Doyeux; S Hapdey; A Edet-Sanson; P Vera; I Gardin
Journal:  Phys Med Biol       Date:  2009-10-28       Impact factor: 3.609

2.  Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.

Authors:  David Groheux; Sylvie Giacchetti; Jean-Luc Moretti; Raphael Porcher; Marc Espié; Jacqueline Lehmann-Che; Anne de Roquancourt; Anne-Sophie Hamy; Caroline Cuvier; Laetitia Vercellino; Elif Hindié
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-11-06       Impact factor: 9.236

3.  Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

Authors:  David Groheux; Mohamed Majdoub; Florent Tixier; Catherine Cheze Le Rest; Antoine Martineau; Pascal Merlet; Marc Espié; Anne de Roquancourt; Elif Hindié; Mathieu Hatt; Dimitris Visvikis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07-04       Impact factor: 9.236

4.  Comparison of Tumor Uptake Heterogeneity Characterization Between Static and Parametric 18F-FDG PET Images in Non-Small Cell Lung Cancer.

Authors:  Florent Tixier; Dennis Vriens; Catherine Cheze-Le Rest; Mathieu Hatt; Jonathan A Disselhorst; Wim J G Oyen; Lioe-Fee de Geus-Oei; Eric P Visser; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2016-03-10       Impact factor: 10.057

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort.

Authors:  Mathieu Hatt; Mohamed Majdoub; Martin Vallières; Florent Tixier; Catherine Cheze Le Rest; David Groheux; Elif Hindié; Antoine Martineau; Olivier Pradier; Roland Hustinx; Remy Perdrisot; Remy Guillevin; Issam El Naqa; Dimitris Visvikis
Journal:  J Nucl Med       Date:  2014-12-11       Impact factor: 10.057

7.  Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome.

Authors:  Janet F Eary; Finbarr O'Sullivan; Janet O'Sullivan; Ernest U Conrad
Journal:  J Nucl Med       Date:  2008-11-07       Impact factor: 10.057

8.  Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

Authors:  David Groheux; Mathieu Hatt; Elif Hindié; Sylvie Giacchetti; Patricia de Cremoux; Jacqueline Lehmann-Che; Antoine Martineau; Michel Marty; Caroline Cuvier; Catherine Cheze-Le Rest; Anne de Roquancourt; Dimitris Visvikis; Marc Espié
Journal:  Cancer       Date:  2013-03-15       Impact factor: 6.860

Review 9.  ¹⁸F-FDG PET/CT for Staging and Restaging of Breast Cancer.

Authors:  David Groheux; Alexandre Cochet; Olivier Humbert; Jean-Louis Alberini; Elif Hindié; David Mankoff
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

10.  Utility of (18)F FDG-PET/CT for predicting prognosis of luminal-type breast cancer.

Authors:  Kenjiro Aogi; Takayuki Kadoya; Yoshifumi Sugawara; Sachiko Kiyoto; Hideo Shigematsu; Norio Masumoto; Morihito Okada
Journal:  Breast Cancer Res Treat       Date:  2015-02-20       Impact factor: 4.872

View more
  15 in total

1.  PET/CT radiomics in breast cancer: promising tool for prediction of pathological response to neoadjuvant chemotherapy.

Authors:  Lidija Antunovic; Rita De Sanctis; Luca Cozzi; Margarita Kirienko; Andrea Sagona; Rosalba Torrisi; Corrado Tinterri; Armando Santoro; Arturo Chiti; Renata Zelic; Martina Sollini
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-03-26       Impact factor: 9.236

Review 2.  Radiomics in Oncological PET/CT: Clinical Applications.

Authors:  Jeong Won Lee; Sang Mi Lee
Journal:  Nucl Med Mol Imaging       Date:  2017-10-20

3.  Biological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass 18F-FDG PET/CT.

Authors:  Neree Payan; Benoit Presles; François Brunotte; Charles Coutant; Isabelle Desmoulins; Jean-Marc Vrigneaud; Alexandre Cochet
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-08       Impact factor: 9.236

4.  Texture analysis of high-resolution dedicated breast 18 F-FDG PET images correlates with immunohistochemical factors and subtype of breast cancer.

Authors:  Alexis Moscoso; Álvaro Ruibal; Inés Domínguez-Prado; Anxo Fernández-Ferreiro; Míchel Herranz; Luis Albaina; Sonia Argibay; Jesús Silva-Rodríguez; Juan Pardo-Montero; Pablo Aguiar
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-09-21       Impact factor: 9.236

Review 5.  Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic Cancers.

Authors:  David Morland; Elizabeth Katherine Anna Triumbari; Luca Boldrini; Roberto Gatta; Daniele Pizzuto; Salvatore Annunziata
Journal:  Diagnostics (Basel)       Date:  2022-05-27

6.  Is FDG-PET texture analysis related to intratumor biological heterogeneity in lung cancer?

Authors:  Manuel Piñeiro-Fiel; Alexis Moscoso; Lucía Lado-Cacheiro; María Pombo-Pasín; David Rey-Bretal; Noemí Gómez-Lado; Cristina Mondelo-García; Jesús Silva-Rodríguez; Virginia Pubul; Manuel Sánchez; Álvaro Ruibal; Pablo Aguiar
Journal:  Eur Radiol       Date:  2020-11-27       Impact factor: 5.315

7.  Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast.

Authors:  Chin-Chuan Chang; Chao-Jung Chen; Wen-Ling Hsu; Shu-Min Chang; Ying-Fong Huang; Yu-Chang Tyan
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

8.  Additional Value of PET/CT-Based Radiomics to Metabolic Parameters in Diagnosing Lynch Syndrome and Predicting PD1 Expression in Endometrial Carcinoma.

Authors:  Xinghao Wang; Ke Wu; Xiaoran Li; Junjie Jin; Yang Yu; Hongzan Sun
Journal:  Front Oncol       Date:  2021-05-12       Impact factor: 6.244

9.  Prognostic Value of Computed Tomography and/or 18F-Fluorodeoxyglucose Positron Emission Tomography Radiomics Features in Locally Advanced Non-small Cell Lung Cancer.

Authors:  Angel Moran; Yichuan Wang; Brandon A Dyer; Stephen S F Yip; Megan E Daly; Tokihiro Yamamoto
Journal:  Clin Lung Cancer       Date:  2021-03-27       Impact factor: 4.840

10.  Texture Analysis Improves the Value of Pretreatment 18F-FDG PET/CT in Predicting Interim Response of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma.

Authors:  Yiwen Sun; Xiangmei Qiao; Chong Jiang; Song Liu; Zhengyang Zhou
Journal:  Contrast Media Mol Imaging       Date:  2020-08-21       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.